Abstract
Introduction and Aims: We undertook this study to detemine the results of acetabular fixation using the Duraloc 300 uncemented acetabular component in patients with inflammatory joint disease and poor bone stock.
Method: Fifty consecutive total hip replacements using a Duraloc 300 cup in patients with imflammatory joint disease were reviewed at an average of 8.2 years. Postoperative x-rays were analysed for cup placement and interface gaps. Follow-up films were analysed for lucent lines, osteolysis, wear and migration. Kaplan-Meier survivorship analysis was performed.
Results: All components were found to be stable with no evidence of loosening or migration.
One patient developed sepsis seven years post-surgery. There was no evidence of excessive wear or osteolysis.
Conclusion: The Duraloc 300 cementless acetabular component has excellent fixation with no cases of loosening at an average of 8.2 years in patients with inflammatory joint disease. The low rate of wear and pelvic osteolysis may be indicative of the decreased demands placed on the prosthesis in this cohort of patients. The poor bone stock has not however adversely effected acetabular fixation.
These abstracts were prepared by Editorial Secretary, George Sikorski. Correspondence should be addressed to Australian Orthopaedic Association, Ground Floor, The William Bland Centre, 229 Macquarie Street, Sydney, NSW 2000, Australia.
At least one of the authors is receiving or has received material benefits or support from a commercial source.
